Trial Profile
Randomised Double-blind Placebo Controlled Study to Measure the Effect of Antiretroviral Therapy (ART) Intensification With Raltegravir and/or Hyper-immune Bovine Colostrum on CD4+ T Cell Count in ART Treated, HIV-1 Infected Individuals With Suboptimal CD4+ T Cell Responses
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Colostrum (Primary) ; Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms CORAL
- 19 Sep 2011 Results published in the Journal of Infectious Diseases.
- 19 Sep 2011 Status changed from active, no longer recruiting to discontinued, according to results published in the Journal of Infectious Diseases.
- 11 Jul 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry).